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The interaction of antibodies and lymphocytes in target cell destruction received 
attention already in the early phase of the studies concerning the mechanism of graft 
rejection. The enhancement phenomenon  indicated that  this interaction can be de- 
cisive for  the  fate of an  antigenic graft  (1).  The  demonstration of at  least partial 
abolishment of cytotoxic activity of sensitized lymphocyte population in vitro when 
antibody-coated cells were used as targets was pointing to a possible shielding effect of 
the antigen sites by antibodies. Lately much attention was focused on the nature and 
significance of this blocking effect (2). In certain systems, however, antibody treatment 
of  the  target  cells was  shown  to  bring about  cytotoxicity effected by  nonimmune 
lymphocyte population (3, 4). The demonstration of these antibody-dependent effects 
with opposite direction raises the question of their relative importance in vivo and also 
in the cytotoxic systems studied in vitro. We have previously demonstrated that when 
cells carrying the MSV-determined surface antigen were pretreated with specific anti- 
body and exposed to sensitized lymphocytes, thereafter the direction of the antibody 
effect and consequently the resulting cytotoxicity depended on the concentration (5). 
High concentration resulted in more efficient destruction while lower concentration 
protected the cells. 
These  experiments  prompted  us  to  continue  these  studies with  attention 
focused on the relative efficiency of these two nlechanisrns bearing in mind that 
each pattern obtained would certainly be relevant in details only in the particu- 
lar systems used. 
Malerials and Methods 
Tissue Culture Medium.--Eagle's  medium  (Grand Island Biological Co.,  Grand Island, 
N.Y.) containing  10% heat-inactivated (at 56°C for 30 min) fetal calf serum (Bio-Cult, Glas- 
gow, Scotland)  with penicillin and streptomycin were used  throughout the experiments  as 
washing fluid, as diluent, and as culture media. 
Target Cells.--Two  different  types of  target cells were  used.  (a)  A  Moloney  leukemia 
virus-induced ascitic lymphoma of A/Sn origin (YAC) (6), harvested 4-6 days after inocula- 
tion of 106 cells by washing  the peritoneal cavity with sterile balanced salt solution  (BSS). 
(b) A tissue culture line of P815-X2, a methylcholanthrene-induced  mastocytoma (7). 
* These  investigations were  conducted  under  contract no.  NIH-NCI-E-69-2005  within 
the Special Virus Cancer  Program of the National Cancer  Institute, National Institutes of 
Health,  U. S.  Public Health  Service.  Grants were  also received  from  the Swedish Cancer 
Society and the Damon  Runyon Memorial Fund (DRG-1064-B). 
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Target Cell Labeling.--Twice-washed  YAC cells were incubated for 30  rain at 37°C  at a 
concentration of 2 X  107 cells suspended in 0.5 ml of BSS with 200 ¢zCi of ~lCr  (The Radio- 
chemical Centre, Amersham, England). The P815  cells were incubated for 4 h  at 37°C at a 
concentration of 2 X  106 cells/10 ml of tissue culture medium with 200/~Ci of 51Cr. The cells 
were washed twice, counted, and adjusted to the desired cell density. 
E ffector Cells.--The spleen or the regional  lymph nodes of adult CBA mice were pressed 
through a fine mesh wire and washed twice. Cell viability was checked with trypan blue. For 
immune cells CBA mice were injected intraperitoneally one to three times with 3 X  107 YAC 
cells 3-6 wk apart. 
Immune Sera.--Hyperimmune sera were obtained from CBA mice immunized with 3 X  107 
YAC cells intraperitoneally with 2-wk intervals during 6-8 wk. This yielded antibodies against 
the D  end of the H-2" complex and also against Moloney virus-determined antigen specifici- 
ties present on the YAC cell. All sera were inactivated at 56°C for 30 min. 
Pretreatment of Target Cells with Sera.--Labeled target cells were incubated with different 
concentrations of normal or immune serum at room temperature for 30 rain. In order to re- 
move excess antiserum the cells were washed once, except in the experiment presented in Fig. 3 
where the serum was present during the incubation with lymphocytes. 
Assay  Procedures.--Cell-mediated  cytotoxicity was  measured  by  a  modification  (8)  of 
Brunner's method (9).  1-ml aliquots of effector cell suspensions were added to 35  X  10 mm 
Petri dishes (NUNCLON®). To each dish 4 X  ]0 4 ~lCr-labeled  target cells were added (0.05 
ml). The target cells were also incubated without effector cells to estimate the level of spon- 
taneous 51Cr release.  Each  cell  sample was  separately estimated for  spontaneous  release. 
Various effector cell concentrations were used to obtain the desired immune target cell  ratio. 
All combinations were prepared in duplicates. The dishes were incubated on a  rocking plat- 
form in a 37°C CO2 incubator for 3.5-4 h  (in the experiment given in Fig. 3,  17 h). After in- 
cubation 1 ml of cold medium was added to each dish and the contents were transferred to 
test tubes. After centrifugation the cell-free  supernatants were counted for the presence of 
5aCr. Maximum release was determined by treating the target cells with distilled water, which 
released approximately 70% of the total 51Cr. 
Evaluation  of the Results.--After  subtraction of  the background,  the alCr  release is ex- 
pressed as percentage of the maximum release. 
RESULTS 
We have found  regularly  that spleen cells  damaged antibody-pretreated  YAC 
or P815 target cells. This  effect  was only  seen with spleen cells  and to a smaller 
extent with peritoneal  cells  and not with lymph  node  cells (Fig. i). 
In three experiments antibody-coated  cells were lysed by spleen cells from 
thymus-less nude mice. In  two  experiments these cells were more efficient 
than those  of the conventional  mice. Fig. 2 gives  the results  using anti-D serum- 
pretreated P815 target cells showing the relatively  higher }ytic  potency of nude 
spleen cells. 
To assess the interaction of immune cells and antibodies the cytotoxic effect 
of immune  cells  after  a  single  immunization  was  investigated after  different 
intervals both without and with precoating the P815  target cells with immune 
serum (Table  I). The efficiency of lysis of antibody-coated ceils fluctuated but 
was  higher in  this  experiment when compared with  the  lysis effected by  the 
immunopotent cells alone. It seems that the former effect tends to be weaker as 
the immune cell population becomes more effective. As there is an inverse cor- 60. 
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EFFECTOR: TARGET CELL RATIO 
FIC. 1. Cytotoxic effect of CBA spleen (0),  lymph node (O), and peritoneal  exudate  (X) 
cells on YAC cells preincubated with 1:20 diluted CBA anti-YAC  (---)  and CBA normal (--) 
sera.  The spontaneous  release  by the serum-treated  samples is indicated  (NS, IS). 
60. 
w 
ao 
.<,,  4o 
.u 
20  ---o 
Isa  2  ~'x  ___-------  x 
i  i  , 
I00:1  53:1  I1:1 
EFFECTOR  :  TARGET  CELL  RATIO 
FIG. 2. Cytotoxic effect of spleen  cells from nude  BALB/c  (X)  or  (DBA/2  X  Leaden)F1 
(0)  mice on P815  target cells pretreated with  1:20 diluted  CBA  anti-YAC  (---)  serum with 
variation  in  the  effector  to  target  cell  ratios.  Normal  serum-pretreated  target  cells  (--). 
The  spontaneous  release  by  the  serum-treated  samples  is indicated  (SR). 
TABLE I 
Cytotoxic Effect  of CBA Spleen  Cells Different  Times after Immunization  with 3 X  10  7 
YA C Cells Intraperitoneally* 
Sera used for pretreatment (1/10) 
Time after  no. of cells per  Normal  Anti-D 
immunization~  spleen X10  ~ 
cpm  ~ICr release  cpm  alCr release 
days  %  % 
Untreated  48  904  17  3,160  58 
4  44  I,I10  20  3,565  65 
10  66  1,576  29  2,236  41 
13  83  1,027  19  1,741  32 
22  70  1,420  26  2,252  41 
22, 14th day after  70  2,043  37  2,390  44 
2d challenge 
Maximum release 5,450 cpm; spontaneous release 498-608 cpm. 
* Target cells P815; lymphocyte to target cell ratio, 100 : 1. 
:~ Each population was derived from two mice. The experiment was performed  on the same  day, the mice 
being immunized previously with different intervals. 530  KIESSLING AND KLEIN  BRIEF  DEFINITIVE REPORT 
relation  with  the  total  cell number in  the  spleen,  the  cells responsible  for the 
increased number  after  immunization  may not  be  operative  in the  antibody- 
mediated  lysis.  Consequently the  relative proportion of efficient cells becomes 
lower because a constant cell  number was used throughout. Only 4  days after 
immunization  higher  51Cr release  was  noted  compared  with  the  spleen  cells 
from the untreated  controls.  The lower efficiency of spleen  cells  from  immu- 
nized animals in mediating the  lysis  of antibody-coated  P815  or YAC  target 
cells  was  observed  in  five  further  experiments.  Under  these  conditions  no 
blocking effect of the  antiserum  was observed  as the  antibody-treated  target 
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SERUM  DiLUTiON 
Fro. 3. Effect of spleen cells from untreated  (----) or immunized (--) CBA mice (6 days 
after one injection of YAC cells) on P815 target cells. CBA anti-YAC serum (X) or CBA nor- 
mal serum (O) was added to the medium in different concentrations and present during the 
incubation  (17 h). Effector to target cell ratio 25:1. Spontaneous release 22 25%. 
cells confronted with the immune cells released in all samples higher amount of 
51Cr than those treated with normal serum. 
The clear opposite effect of antibody in relation to the effector cell population 
was obtained under  slightly different conditions  (Fig. 3). Antibody excess was 
not removed and the interaction of P815 target and effector cells was prolonged 
(17  h).  Dependent  on  the  serum  concentration  a  clear blocking effect of the 
immune effector lysis is seen. The blocking serum concentrations in combination 
with normal spleen cell population result however in lysis. The fact that block- 
ing effect is  present  may indicate  that  the  cells responsible  for mediating  the 
antibody complexed cell lysis are scarce in the immune cell population. 
DISCUSSION 
Both the mouse lymphonla cells YAC harvested from animals and the in vitro 
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by normal spleen cells if the cells are coated with antibodies directed against the 
H-2 (and Moloney virus determined for the YAC) surface antigens. Similarly to 
the  previously often  demonstrated  effect of  antibodies  on  the  immune  cell 
killing, here also a blocking was demonstrated, the extent of which dependend 
on the conditions. In spite of the fact that in some experiments the lyric effects 
were only moderately effective and thus synergism could have been detected, 
this was observed only in one case when an immune cell population was used. 
On the contrary it seems that the immune spleen cell population is less potent in 
bringing the antibody-dependent cytotoxicity in effect. This might be due to a 
change in the population after immunization resulting in lowering the propor- 
tion of the relevant cells. 
It is noteworthy that the results obtained here resemble that  of an entirely 
in  vitro  system.  In  the  chicken  erythrocyte target-rabbit  antiserum-human 
lymphocyte effector cell system, Perlmann et al. (10) have shown thatpreceding 
interaction with the antigen-antibody complex made the lymphocytes acquire a 
low but definite cytotoxic potential on target cells without antibody coat. The 
important finding relevant to our results was that these lymphocytes were con- 
siderably less active in lysing antibody-coated chicken erythrocytes. McLennan 
has also shown that unrelated antigen-antibody complexes are  also inhibitory 
(11). It is also possible therefore that the weaker potential of the immune spleen 
cell population is due to the effect of immune complexes on the cells in vivo. 
The fact that only spleen cells were found to mediate lysis of antibody-coated 
target cells corresponds well  to the analysis of the  mechanism regarding the 
source of the effector cell.  It is proposed that  the cell is bone marrow-derived 
(B cell) (12) and lymph nodes are relatively poor in B cells (13). The relatively 
higher efficiency of cell population derived from the thymus-less nude mice, the 
lower efficiency of immune spleen in which probably thymus-derived cells are 
enriched provides further evidence that the cytolytic effect is bound  to non- 
thymus-derived cells. 
We are grateful to Mrs. Karin Kvarnung for her excellent technical assistance. 
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